Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc. | Ownership

Companies that own Cancer Genetics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Stonepine Capital Management LLC
1,391,607
5.01%
-381,134
0.73%
06/30/2018
Perkins Capital Management, Inc.
1,004,550
3.62%
40,950
0.55%
06/30/2018
Renaissance Technologies LLC
587,300
2.12%
105,900
0%
06/30/2018
Granahan Investment Management, Inc.
276,417
1%
40,915
0.01%
06/30/2018
The Vanguard Group, Inc.
242,280
0.87%
-338,206
0%
06/30/2018
Fairbanks Capital Management, Inc.
234,170
0.84%
0
0.23%
06/30/2018
Geode Capital Management LLC
107,355
0.39%
20,076
0%
06/30/2018
Diker Management LLC
64,365
0.23%
0
0.02%
06/30/2018
Wedbush Securities, Inc. (Investment Management)
52,310
0.19%
4,510
0.01%
06/30/2018
PanAgora Asset Management, Inc.
43,664
0.16%
43,664
0%
06/30/2018

About Cancer Genetics

View Profile
Address
Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Website http://www.cancergenetics.com
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.